GlassScriptPhysician profile
Anthony J Brandau
NPI 1346560182
$9,267.76
in general payments reported to CMS, 2019-2025
74 companies · $1,843 in 2025
The $1,843 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $835 · 2021: $1,416 · 2022: $1,704 · 2023: $1,764 · 2024: $1,189 · 2025: $1,843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,592 · Education: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,591.98 |
| Education | $203.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $703.09 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Astrazeneca Pharmaceuticals LP | $668.18 | 2019-2025 | Calquence, Enhertu, Lynparza |
| Genentech USA, INC. | $601.71 | 2019-2025 | Polivy, Phesgo, Lunsumio |
| Novartis Pharmaceuticals Corporation | $563.58 | 2022-2025 | |
| Janssen Biotech, INC. | $450.46 | 2021-2025 | Erleada, Rybrevant, Tecvayli |
| Amgen INC. | $450.24 | 2019-2023 | Kyprolis, Blincyto, Xgeva |
| Celgene Corporation | $436.27 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Pfizer INC. | $376.11 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $366.34 | 2019-2025 | Ninlaro, Alunbrig, Iclusig |
| Genzyme Corporation | $297.92 | 2019-2025 | |
| Seagen INC. | $229.70 | 2020-2025 | Tukysa, Padcev |
| E.R. Squibb & Sons, L.L.C. | $216.10 | 2019-2025 | Opdivo |
| Eisai INC. | $209.20 | 2020-2024 | |
| Incyte Corporation | $192.87 | 2021-2025 | Jakafi, Monjuvi |
| Regeneron Healthcare Solutions, INC. | $176.30 | 2022-2025 | Libtayo, Lynozyfic |
Show all 74 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $170.25 | 2020-2025 | Enhertu, Injectafer |
| Glaxosmithkline, LLC. | $161.62 | 2021-2025 | Ojjaara, Jemperli, Zejula |
| Epizyme, INC. | $154.81 | 2020-2022 | |
| Lilly USA, LLC | $153.82 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Emd Serono, INC. | $145.22 | 2019-2023 | Bavencio, Tepmetko |
| Jazz Pharmaceuticals INC. | $140.35 | 2020-2025 | |
| Abbvie INC. | $132.51 | 2021-2025 | Lupron Depot |
| Rigel Pharmaceuticals, INC. | $104.97 | 2020-2024 | Rezlidhia, Tavalisse |
| Sanofi-Aventis U.S. LLC | $99.99 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $95.02 | 2020-2022 | |
| Tersera Therapeutics LLC | $88.68 | 2022-2025 | Zoladex, Xermelo |
| Springworks Therapeutics, INC. | $88.34 | 2024-2025 | Ogsiveo |
| Aveo Pharmaceuticals, INC. | $87.56 | 2022-2025 | Fotivda |
| Array Biopharma INC | $84.69 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Puma Biotechnology, INC. | $80.47 | 2019-2025 | |
| Kite Pharma, INC. | $70.45 | 2021-2025 | Yescarta |
| Zimmer Biomet Holdings, INC. | $66.10 | 2022 | |
| Astellas Pharma US INC | $63.71 | 2019-2025 | Padcev, Xospata |
| Ipsen Biopharmaceuticals, INC | $61.13 | 2021-2023 | Onivyde, Somatuline Depot |
| Genmab U.S., INC. | $58.52 | 2025 | Epkinly |
| Taiho Oncology, INC. | $57.38 | 2021-2024 | |
| Gilead Sciences, INC. | $57.24 | 2022-2023 | |
| Mylan Institutional INC. | $57.24 | 2019-2022 | |
| Pharmaessentia USA Corporation | $54.99 | 2022-2025 | Besremi |
| Bayer Healthcare Pharmaceuticals INC. | $53.08 | 2022-2024 | |
| Dendreon Pharmaceuticals LLC | $52.92 | 2024-2025 | Provenge |
| Alexion Pharmaceuticals, INC. | $52.45 | 2019-2023 | |
| Acrotech Biopharma INC. | $49.30 | 2021-2023 | Beleodaq |
| Beigene USA, INC. | $47.22 | 2020-2022 | |
| Acceleron Pharma, INC. | $44.83 | 2020-2021 | |
| Beone Medicines USA, INC. | $43.53 | 2025 | Brukinsa, Tevimbra |
| Clovis Oncology, INC. | $40.68 | 2020 | |
| Mirati Therapeutics, INC. | $39.75 | 2023-2024 | Krazati |
| Sumitomo Pharma America, INC. | $39.46 | 2023-2024 | Orgovyx |
| Morphosys, US INC. | $37.85 | 2021 | |
| Deciphera Pharmaceuticals INC. | $35.92 | 2022-2023 | Qinlock |
| Kyowa Kirin, INC. | $34.58 | 2025 | |
| Stemline Therapeutics INC. | $28.39 | 2023-2024 | Orserdu |
| Foundation Medicine, INC. | $25.06 | 2022-2023 | |
| Sanofi US Services INC. | $24.88 | 2025 | |
| Exelixis INC. | $23.52 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $22.14 | 2023 | Pylarify |
| Coherus Oncology, INC. | $22.08 | 2022 | |
| Octapharma USA, INC. | $21.86 | 2023 | Panzyga |
| Eagle Pharmaceuticals, INC. | $20.64 | 2022 | |
| Alnylam Pharmaceuticals INC. | $20.51 | 2022 | |
| Myovant Sciences INC. | $20.33 | 2021 | |
| Organon LLC | $19.61 | 2023 | Ontruzant |
| Spectrum Pharmaceuticals INC. | $18.98 | 2024 | Rolvedon |
| Blue Earth Diagnostics | $18.23 | 2021 | |
| Adc Therapeutics America, INC. | $18.21 | 2022 | |
| Immunomedics, INC. | $16.91 | 2020 | |
| Dova Pharmaceuticals | $16.23 | 2020 | |
| Medtronic, INC. | $15.61 | 2025 | Osteocool Rf Ablation System |
| Tesaro, INC. | $15.08 | 2019 | |
| Lundbeck LLC | $15.01 | 2021 | |
| Pharmacosmos Therapeutics INC. | $14.17 | 2023 | Monoferric |
| Boston Scientific Corporation | $13.43 | 2024 | |
| Karyopharm Therapeutics INC. | $12.18 | 2021 |
Drugs and devices associated with these payments
Keytruda $438Lynparza $279Kisqali $232Enhertu $140Polivy $127Opdivo $115Reblozyl $114Phesgo $111Jakafi $105Calquence $88.80Libtayo $88.64Ogsiveo $88.34Lunsumio $87.24Tecentriq $86.72Promacta $81.61Erleada $79.29Orgovyx $78.37Zepzelca $75.92Keytruda Qlex $75.56Padcev $72.04Columvi $71.42Sarclisa $70.00Venclexta $68.32Pomalyst $66.47Bosulif $65.14Pluvicto $64.81Rybrevant $64.14Elrexfio $63.05Tukysa $63.05Adcetris $63.05Fabhalta $58.55Epkinly $58.52Lenvima $56.70Tecvayli $55.16Jaypirca $54.14Verzenio $54.14Fotivda $54.11Provenge $52.92Zoladex $52.89Opdualag $52.45Braftovi $51.86Mektovi $51.86Kyprolis $51.82Darzalex $48.73Imbruvica $48.67Ojjaara $45.11Ninlaro $43.53Perjeta $42.56Itovebi $42.53Lonsurf $42.13Tagrisso $40.89Rezlidhia $40.37Tavalisse $40.37Krazati $39.75Lutathera $39.39Scemblix $38.97Xtandi $38.91Monjuvi $38.25Inlyta $37.83Yescarta $36.50Blincyto $34.95Poteligeo $34.58Lupron Depot $32.36Lynozyfic $31.24Retevmo $31.08Lorbrena $29.50Orserdu $28.39Alunbrig $27.36Alecensa $26.01Rozlytrek $26.01Injectafer $25.88Kadcyla $25.03Ayvakit $24.88Jevtana $23.58Iclusig $23.11Brukinsa $23.06Besremi $22.21Pylarify $22.14Panzyga $21.86Somatuline Depot $21.62Onivyde $21.62Zejula $20.56Jemperli $20.56Tevimbra $20.47Stivarga $20.32Vitrakvi $20.32Blenrep $19.99Qinlock $19.98Nerlynx $19.76Ontruzant $19.61Imfinzi $19.48Paxlovid $19.23Comirnaty $19.23Ibrance $19.23Rolvedon $18.98Inqovi $18.83Besponsa $18.40Akeega $18.24Tasigna $18.10Xospata $17.49
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Brandau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.